Familial Chylomicronemia Syndrome
·MeSH: Familial hyperchylomicronemia syndrome
Prevalence
0.5 / 100K
4 drugs in development·4 companies·5 clinical trials
Drug Pipeline by Phase
Approved(3)
Phase 2(1)
| Drug | Company |
|---|---|
| olezarsen | IONIS PHARMACEUTICALS INC (IONS) |
Compare drugs
Frequently asked questions
How many drugs are in development for Familial Chylomicronemia Syndrome?
BioSniper tracks 4 drugs in development for Familial Chylomicronemia Syndrome across 4 companies.
How many clinical trials target Familial Chylomicronemia Syndrome?
There are 5 clinical trials targeting Familial Chylomicronemia Syndrome tracked by BioSniper.
What is the prevalence of Familial Chylomicronemia Syndrome?
The estimated prevalence of Familial Chylomicronemia Syndrome is approximately 0.5 per 100,000 population.
Deep-dive into Familial Chylomicronemia Syndrome
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis